SCHEMBL7667775

SCHEMBL7667775

Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)N[C@H](C)C(=O)OCc3ccccc3)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 4/20 0.66
MMP2 P08253 2/20 0.54
MAPT P10636 3/20 0.53
LMNA P02545 3/20 0.51
HPN P05981 4/20 0.51
PLAU P00749 3/20 0.51
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
CTSL P07711 1/20 0.49
ALDH1A1 P00352 4/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
KDM4E B2RXH2 1/20 0.48
POLB P06746 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689105 0.89 ALDH1A1 (0.56) MMP9MMP2MAPTLMNACTSL
SCHEMBL7667779 0.88 MMP9 (0.52) MMP9MMP2MAPTLMNAMEN1
SCHEMBL7674729 0.82 MMP9 (0.66) MMP9MMP2MAPTLMNAHPN
SCHEMBL7670593 0.81 LMNA (0.55) MMP9MMP2MAPTLMNAHPN
SCHEMBL7675164 0.80 MMP9 (0.52) MMP9MMP2MAPTLMNAHPN
SCHEMBL5093780 0.80 MMP9 (1.00) MMP9MMP2MAPTHPNPLAU
SCHEMBL7669356 0.80 MMP9 (1.00) MMP9MMP2MAPTHPNPLAU
SCHEMBL7583642 0.79 MMP9 (0.70) MMP9MMP2
SCHEMBL5221010 0.78 LMNA (0.55) MMP9MMP2MAPTLMNAHPN
SCHEMBL7673629 0.78 MMP9 (0.76) MMP9MMP2MAPTHPNPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed